Treatment of Recurrent Chronic Ulcerative Dermatitis in a Bottlenose Dolphin (Tursiops truncatus)
IAAAM 2011
Bethany M. Doescher1; Johanna Mejia-Fava2,3; Carmen Colitz4; Norma Pestano5; Pedro Perez6; Jeff Pawloski1
1Sea Life Park Hawaii, Waimanalo, HI, USA; 2University of Georgia, College of Veterinary Medicine, Athens, GA, USA; 3Animal Necessity, LLC., Athens, GA, USA; 4Aquatic Animal Eye Care, LLC., Jupiter, FL, USA; 5Alternativa Natural, Inc., Brooklyn, NY, USA; 6Innovation Laboratories, Inc., Mount Sinai, NY, USA

Abstract

A 41 year old female bottlenose dolphin (Tursiops truncatus) had 10 year history of recurrent ulcerative dermatitis. In each case the lesion reported at initial presentation was unremarkable, but became increased in number and diameter secondary to frequent repeated bouts of excessive rubbing. Multiple medical therapies and behavioral modification techniques were utilized to address the wound infection as well as the rubbing behavior, but none proved to be successful long term. Over time, she developed a persistent leukocytosis that seemed unresponsive to therapy. Her age and the chronicity of the condition lead to concerns about the functionality of her immune system and her ability to fight infection. A multifactorial approach was used to address the different components of her condition which included Animal Necessity, LLC. Imuno-2865TM (NatramuneTM), Serenin VetTM, as well as oral and topical ShanaTM (TopicalPlus®). Imuno-2865TM is a natural hemicellulose made of arabinoxylan, arabinogalactan, and fatty acid mixture extracted by a proprietary process from a natural blend of gramineae, poaceae, and dioscoreaceae. In human pilot studies, Imuno-2865TM has shown encouraging findings in improving lymphocyte activation and interleukin activity. 1-4 Shana VetTM is a blend of natural phytowaxes and botanical extract with amino acids and vitamins that protect the epidermis, fur, and nails to aid in the prevention of fungal disease. One of the active ingredients is docosanol which inhibits viral replication by interfering with the early intracellular events surrounding viral entry into target cells.5 The supplement also contains Triacontanol (TRIA), one of the ingredients has been known to exhibit anti-inflammatory action in animals and this anti-inflammatory effect of TRIA might be mediated through inhibition of lipid peroxidation.6 Serenin VetTM is a unique blend of natural vitamins and extracts used in marine mammals to help with dominance aggression and submission apprehensiveness.7,8

References

1.  Chavoustie S, Perez P, Fletcher M, Maher K, Mitrani A, Thomas R. Pilot study: effect of PDS-2865® on natural killer cell cytotoxicity. Journal on Nutraceuticals and Nutrition 2003; 6(2): 39–42.

2.  Chavoustie S, Perez P, Fletcher M, Maher, Mitrani A, Thomas R. 2002. Initial clinical study on Natramune TM (IN-2865) at The Clinical Immunology-University of Miami School of Medicine.

3.  Rodriguez MM, Mejia JC, Blanchard MT, Stott J, Pestano N, Perez PP. Pilot Study: The Affects of NatramuneTM (PDS-2865®), a New immunostimulator supplement on different cetacean species; Tursiops truncatus, Lagenorhynchus obliquidens, and Orcinus orca. IAAAM 38th Annual Conference Proceedings, Orlando, FL; 2007; pp. 44–45.

4.  Rodriguez MM, Mejia JC, Blanchard MT, Stott J, Pestano N, Perez PP. NatramuneTM (PDS-2865®), an immuno-stimulator supplement in cetaceans. IAAAM 39th Annual Conference Proceedings, Pomezia, Italy; 2007; pp. 26.

5.  Katz DH, Marcelletti JF, Khalil MH, Pope LE, Katz LR. Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. Proc Natl Acad Sci USA 1991; 88(23): 10825–9.

6.  Ramanarayan K, Bhat A, Shripathi V, Swamy GS, Rao KS. Triacontanol inhibits both enzymatic and nonenzymatic lipid peroxidation. Phytochemistry 2000; 55(1): 59–66.

7.  Berman F, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 1999; 61: 712–728.

8.  Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John's wort) in major depressive disorder: a randomized controlled trial. Journal of the American Medical Association 2002; 287(14): 1807–1814.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Bethany M. Doescher
Sea Life Park Hawaii
Waimanalo, HI, USA


MAIN : Case Reports II : Chronic Ulcerative Dermatitis
Powered By VIN
SAID=27